Produced by Araxis Merge on 10/2/2017 3:33:02 PM Eastern Daylight Time. See www.araxis.com for information about Merge. This report uses XHTML and CSS2, and is best viewed with a modern standards-compliant browser. For optimum results when printing this report, use landscape orientation and enable printing of background images and colours in your browser.
| # | Location | File | Last Modified |
|---|---|---|---|
| 1 | OSCIF_ CPRS Enh P1_OR_3.0_439_build_4_August_2017.zip | GMTS_2_7_120_RN.doc | Fri Sep 29 16:04:02 2017 UTC |
| 2 | OSCIF_ CPRS Enh P1_OR_3.0_439_build_4_August_2017.zip | GMTS_2_7_120_RN.doc | Sat Sep 30 01:39:44 2017 UTC |
| Description | Between Files 1 and 2 |
|
|---|---|---|
| Text Blocks | Lines | |
| Unchanged | 1 | 326 |
| Changed | 0 | 0 |
| Inserted | 0 | 0 |
| Removed | 2 | 5 |
| Whitespace | |
|---|---|
| Character case | Differences in character case are significant |
| Line endings | Differences in line endings (CR and LF characters) are ignored |
| CR/LF characters | Not shown in the comparison detail |
No regular expressions were active.
| 1 | CPRS ENHAN CEMENT PHA SE 1 | ||
| 2 | GMTS*2.7* 120 Patch | ||
| 3 | Release No tes | ||
| 4 | |||
| 5 | December 2 016 | ||
| 6 | Department of Vetera ns Affairs | ||
| 7 | Office of Informatio n & Techno logy (OI&T ) | ||
| 8 | Product De velopment (PD) | ||
| 9 | Table of C ontents | ||
| 10 | 2Table of Contents | ||
| 11 | |||
| 12 | |||
| 13 | 3Installat ion Requir ements | ||
| 14 | |||
| 15 | |||
| 16 | 3Required Patches | ||
| 17 | |||
| 18 | |||
| 19 | 3Project D escription | ||
| 20 | |||
| 21 | |||
| 22 | 5Patch Inf ormation | ||
| 23 | |||
| 24 | |||
| 25 | 6Release M ethod | ||
| 26 | |||
| 27 | |||
| 28 | 6New Funct ionality | ||
| 29 | |||
| 30 | |||
| 31 | |||
| 32 | |||
| 33 | Installati on Require ments | ||
| 34 | Required P atches | ||
| 35 | Below is a list of p atches tha t you must verify ar e properly installed on your s ystem befo re CPRS EP 1 GMTS*2.7 *120 and i ts’ associ ated patch es can be installed: | ||
| 36 | GMTS*2.7*1 00 | ||
| 37 | Project De scription | ||
| 38 | Per the Jo int Commis sion’s NPS G.03.06.01 , a medica tion summa ry must be given to a patient upon each admission, discharge , or trans fer. The document u sed curren tly is the Medicatio n Reconcil iation Too l #2 (MRT2 ), which i s the refe rence for the patien t-facing d ocument. The MRT2 p roduced by VistA doe s not disp lay non-VA medicatio n informat ion as tho roughly as it does V A medicati ons. Figur e 1 shows an example of how MR T2 current ly display s. | ||
| 39 | ********** *** CONFI DENTIAL Me dication W orksheet S UMMARY p g. 1 ***** ********* | ||
| 40 | CPRSPATIEN T,EIGHT 666-06-10 08 DOB: 0 4/15/1953 | ||
| 41 | ICU/CCU 7A-BORD | ||
| 42 | ---------- ---------- ----- MRT2 - Medicat ion Worksh eet ------ ---------- --------- | ||
| 43 | Date: Dec 20, 2016 PATIEN T MEDICATI ON INFORMA TION P age: 1 | ||
| 44 | PRINTED B Y THE VA M EDICAL CEN TER AT: CA MP MASTER | ||
| 45 | FOR PRESC RIPTION RE FILLS CALL (518) 472 -4307 | ||
| 46 | Name: CPRS PATIENT,EI GHT PHARMACY - ALBANY D IVISION | ||
| 47 | |--------- ---------- ---------- ---------- ---------- ---------- ---------- ----| | ||
| 48 | | |M ORNING| NO ON |EVENI NG|BEDTIME | CO MMENTS | | ||
| 49 | |~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~| | ||
| 50 | | | | ||
| 51 | |**PENDING ** RANITID INE 150MG TAB | | ||
| 52 | | TAKE ONE TABLE T BY MOUTH BID BREAK FAST/LUNCH | | ||
| 53 | | Quan tity: 180 Refills: 0 | | ||
| 54 | |--------- ---------- ---------- ---------- ---------- ---------- ---------- ----| | ||
| 55 | | UNITS PE R DOSE: | | | | | | | ||
| 56 | |~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~| | ||
| 57 | | | | ||
| 58 | |NON-VA Me dications: | | ||
| 59 | | | | ||
| 60 | |MULTIVITA MINS TAB | | ||
| 61 | |OMEPRAZOL E 20MG EC CAP | | ||
| 62 | |--------- ---------- ---------- ---------- ---------- ---------- ---------- ----| | ||
| 63 | Any medica tion items listed as "pending" are those that have just been | ||
| 64 | written by your prov ider(s). These medi cation ord ers will b e reviewed | ||
| 65 | by your ph armacist, prior to t he prescri ption(s) b eing dispe nsed. Whe n | ||
| 66 | you receiv e your new prescript ion(s), by mail or f rom the ph armacy win dow, | ||
| 67 | be sure to follow th e instruct ions on th e prescrip tion label . If you | ||
| 68 | have any q uestion ab out your m edication, please ca ll your pr ovider or | ||
| 69 | your pharm acist. | ||
| 70 | *** END ** *** CONFI DENTIAL Me dication W orksheet S UMMARY p g. 1 ***** ******** | ||
| 71 | Figure 1. Example of How MRT2 Currently Displays | ||
| 72 | Consequent ly, the VA staff, wh ich is res ponsible f or medicat ion review and couns eling, doe s not have the abili ty to mana ge all asp ects of me dication o rder fulfi llment. Th is could r esult in t he patient being una ware of th e correct medication , dosage, route, and schedule. . | ||
| 73 | One of the challenge s is that non-VA med ication or ders are n ot require d to have all the sa me informa tion as a VA prescri bed medica tion. This enhanceme nt does no t address that issue . No new d ata is req uired due to this en hancement. | ||
| 74 | With this enhancemen t, the per son review ing the Me dication W orksheet w ill have t he ability to genera te a compl ete patien t-facing r eport usin g health s ummary inf ormation t o provide medication , dosage, route, and schedule details ab out docume nted non-V A medicati ons, when available, so that a comprehen sive print out to pat ients for use during medicatio n counseli ng. See Fi gure 2 for an exampl e of a com plete pati ent-facing report us ing health summary i nformation . | ||
| 75 | ********** *** CONFI DENTIAL Me dication W orksheet S UMMARY p g. 1 ***** ********* | ||
| 76 | CPRSPATIEN T,EIGHTYON E 666-0 6-1015 DOB: 0 4/15/1953 | ||
| 77 | ---------- ---------- ----- MRT2 - Medicat ion Worksh eet ------ ---------- --------- | ||
| 78 | Date: Nov 29, 2016 PATIEN T MEDICATI ON INFORMA TION P age: 1 | ||
| 79 | PRINTED B Y THE VA M EDICAL CEN TER AT: CA MP MASTER | ||
| 80 | FOR PRESC RIPTION RE FILLS CALL (518) 472 -4307 | ||
| 81 | Name: CPRS PATIENT,EI GHTYONE PHARMACY - ALBANY D IVISION | ||
| 82 | |--------- ---------- ---------- ---------- ---------- ---------- ---------- ----| | ||
| 83 | | |M ORNING| NO ON |EVENI NG|BEDTIME | CO MMENTS | | ||
| 84 | |~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~| | ||
| 85 | | | | ||
| 86 | |**NON-VA* * ABACAVIR SULFATE 3 00MG TAB | | ||
| 87 | | TAKE ONE TABLE T BY MOUTH | | ||
| 88 | |--------- ---------- ---------- ---------- ---------- ---------- ---------- ----| | ||
| 89 | | UNITS PE R DOSE: | | | | | | | ||
| 90 | |~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~| | ||
| 91 | | | | ||
| 92 | |**NON-VA* * BOSENTAN 62.5MG TA B | | ||
| 93 | | TAKE ONE TABLE T BY MOUTH TWICE A D AY Patien t wants to buy from | | ||
| 94 | | Non- VA pharmac y. | | ||
| 95 | |--------- ---------- ---------- ---------- ---------- ---------- ---------- ----| | ||
| 96 | | UNITS PE R DOSE: | | | | | | | ||
| 97 | |~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~| | ||
| 98 | | | | ||
| 99 | |**NON-VA* * DRONABIN OL CAP,ORA L | | ||
| 100 | | TAKE 1.9MG BY MOUTH | | ||
| 101 | |--------- ---------- ---------- ---------- ---------- ---------- ---------- ----| | ||
| 102 | | UNITS PE R DOSE: | | | | | | | ||
| 103 | |~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~| | ||
| 104 | | | | ||
| 105 | |**PENDING ** ACARBOS E 100MG TA B | | ||
| 106 | | TAKE TWO TABLE TS BY MOUT H TWICE A DAY | | ||
| 107 | | Quan tity: 120 Refills: 0 | | ||
| 108 | |--------- ---------- ---------- ---------- ---------- ---------- ---------- ----| | ||
| 109 | | UNITS PE R DOSE: | | | | | | | ||
| 110 | |~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~| | ||
| 111 | | | | ||
| 112 | |**PENDING ** ALENDRO NATE 35MG TAB | | ||
| 113 | | TAKE ONE TABLE T BY MOUTH TWICE A D AY | | ||
| 114 | | Quan tity: 60 R efills: 0 | | ||
| 115 | |--------- ---------- ---------- ---------- ---------- ---------- ---------- ----| | ||
| 116 | | UNITS PE R DOSE: | | | | | | | ||
| 117 | |~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~| | ||
| 118 | | | | ||
| 119 | |**PENDING ** AMINO A CIDS 5.4% INJ | | ||
| 120 | | AMIN O ACIDS 5. 4% INJ 250 ml IM 120 ml/hr | | ||
| 121 | |--------- ---------- ---------- ---------- ---------- ---------- ---------- ----| | ||
| 122 | | UNITS PE R DOSE: | | | | | | | ||
| 123 | |~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~| | ||
| 124 | Date: Nov 29, 2016 PATIEN T MEDICATI ON INFORMA TION P age: 2 | ||
| 125 | PRINTED B Y THE VA M EDICAL CEN TER AT: CA MP MASTER | ||
| 126 | FOR PRESC RIPTION RE FILLS CALL (518) 472 -4307 | ||
| 127 | Name: CPRS PATIENT,EI GHTYONE PHARMACY - ALBANY D IVISION | ||
| 128 | |--------- ---------- ---------- ---------- ---------- ---------- ---------- ----| | ||
| 129 | | |M ORNING| NO ON |EVENI NG|BEDTIME | CO MMENTS | | ||
| 130 | |~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~| | ||
| 131 | | | | ||
| 132 | |LISINOPRI L 10MG TAB | | ||
| 133 | | TAKE ONE TABLE T BY MOUTH TWICE A D AY | | ||
| 134 | | 0 re fill(s) re maining pr ior to Jan 04, 2017 (Rx #58) | | ||
| 135 | |--------- ---------- ---------- ---------- ---------- ---------- ---------- ----| | ||
| 136 | | UNITS PE R DOSE: | | | | | | | ||
| 137 | |~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~| | ||
| 138 | | | | ||
| 139 | |SUPPLY IT EMS: | | ||
| 140 | |ADHESIVE REMOVER LI QUID | ||
| 141 | |HEMATEST TAB (NOT F OR ORAL US E) | | ||
| 142 | |~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~| | ||
| 143 | Any medica tion items listed as "pending" are those that have just been | ||
| 144 | written by your prov ider(s). These medi cation ord ers will b e reviewed | ||
| 145 | by your ph armacist, prior to t he prescri ption(s) b eing dispe nsed. Whe n | ||
| 146 | you receiv e your new prescript ion(s), by mail or f rom the ph armacy win dow, | ||
| 147 | be sure to follow th e instruct ions on th e prescrip tion label . If you | ||
| 148 | have any q uestion ab out your m edication, please ca ll your pr ovider or | ||
| 149 | your pharm acist. | ||
| 150 | Any medica tion items listed as "NON-VA" are Medica tions you do not get | ||
| 151 | from a VA pharmacy t hat your p rovider re corded in your medic al record. | ||
| 152 | This inclu des medica tion presc ribed by V A or non V A provider s, over th e | ||
| 153 | counter me dications, herbals, samples or other med ications y ou take. | ||
| 154 | *** END ** *** CONFI DENTIAL Me dication W orksheet S UMMARY p g. 1 ***** ******** | ||
| 155 | Figure 2. Complete P atient-Fac ing Report Using Hea lth Summar y Informat ion | ||
| 156 | Patch Info rmation | ||
| 157 | GMTS*2.7*1 20 provide s an enhan cement to the Medica tion Recon ciliation Worksheet (MRT Tool #2) so it will be ca pable of d isplaying non-VA med ication in formation in the sam e way that VA medica tion infor mation is displayed on the pat ient-facin g report. This repor t is gener ated from Health Sum mary data and given to a patie nt when ad mitted, di scharged, or transfe rred. Refe r to Figur e 3 for an example o f the Heal th Summary Medicatio n Workshee t displayi ng non-VA medication the same way VA med ication wo uld be dis played. | ||
| 158 | |||
| 159 | Figure 3. Health Sum mary Medic ation Work sheet Disp laying Non -VA Medica tion | ||
| 160 | Release Me thod | ||
| 161 | This patch will be r eleased vi a the Nati onal Patch Module. | ||
| 162 | New Functi onality | ||
| 163 | NSR 201009 11 – MRT2 Non-VA Med ication Do se Enhance ment | ||
Araxis Merge (but not the data content of this report) is Copyright © 1993-2016 Araxis Ltd (www.araxis.com). All rights reserved.